Efficacy of Endoscopic Mucosal Resection for Management of Small Duodenal Neuroendocrine Tumors

Sagar R Shroff1, Vladimir M Kushnir, Sachin B Wani

  • 1Department of Medicine, Division of Gastroenterology and Hepatology, Washington University, St Louis, MO.

Abstract

Insights

Endoscopic mucosal resection (EMR) for duodenal neuroendocrine tumors (NETs) is effective in select cases. Endoscopic ultrasound (EUS) aids in selecting patients for EMR, improving outcomes for these rare tumors.

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Endocrinology

Background:

  • Small duodenal neuroendocrine tumors (NETs) are rare, making treatment decisions like endoscopic mucosal resection (EMR) controversial.
  • Assessing the efficacy and safety of EMR versus surgery for duodenal NETs is crucial.

Purpose of the Study:

  • To evaluate the disease-free status after EMR and surgical resection of duodenal NETs.
  • To determine the sensitivity of endoscopic ultrasound (EUS) in guiding EMR suitability for duodenal NETs.

Main Methods:

  • Retrospective cohort study of 30 patients with duodenal NETs treated between 2001 and 2011.
  • Comparison of outcomes between EMR (n=20) and surgical resection (n=10).
  • Assessment of EUS sensitivity for identifying submucosal lesions.

Main Results:

  • EMR had a 40% positive margin rate compared to 10% for surgery.
  • Five EMR patients experienced residual disease, requiring further treatment.
  • EUS showed 96% sensitivity in detecting submucosal invasion.

Conclusions:

  • EMR is a viable alternative to surgery for carefully selected duodenal NET patients.
  • EUS is valuable for assessing tumor invasion depth and patient selection for EMR.

Related Concept Videos